Top 10 Cheapest Companies For 2014

Gold is on the rise. The commodity has seen a dramatic surge over the past two months since hitting bottom in late June.

Investing in the metal itself or in a fund like SPDR Gold Trust Shares (NYSE: GLD) are both great ways to play this trend.

But considering the historic lows that we've seen in gold producers, even bigger gains could be made by investing in gold miners.

One of the easiest ways to do this is through the Market Vectors Gold Miners ETF (NYSE: GDX).

Right now, GDX is the cheapest it's been since 2008.

David Einhorn, the billionaire fund manager, is one of the biggest GDX shareholders. His hedge fund Greenlight Capital currently owns 8.8 million shares, making him the fund's fifth-largest institutional shareholder.  

Top Managed Healthcare Companies To Own For 2015: Lennar Corp.(LEN)

The third largest U.S. homebuilder by revenue reported exceptional Q3 results, as its earnings more than quadrupled, primarily as a result of an increase in new-home demand. The reported net income of 40c was well ahead of last year's 11c, and the forecasted 28c.

According to the company's CEO, Stuart Miller, "The homebuilding business is beginning to revert to normal, and that's a positive for the U.S. economy in general, which is in turn good for sustained recovery in the housing market. Overall demand has been improving and we've seen a consistent sales pace at improving prices."

LEN's contract backlog, which is an indicator of future sales, rose by a whopping 79% on a YoY basis. Its average selling price of delivered homes also increased to $258,000 from last year's $247,000.

Advisors' Opinion:

• [By Sue Chang and Saumya Vaishampayan]

  Lennar Corp. (LEN) �rose 4.2% after the home builder said early Tuesday that its third-quarter profit rose 39%. PulteGroup Inc. (PHM) �and D.R. Horton Inc. also recovered from the previous session�� losses to trade higher. Separately, the S&P/Case-Shiller index rose 12.4% in July, its fastest annual pace since 2006.

Top 10 Cheapest Companies For 2014: HomeTrust Bancshares Inc (HTBI)

HomeTrust Bancshares, Inc. is a bank holding company. The Company operates through HomeTrust Bank (the Bank). The Bank is a federally chartered mutual savings bank with 20 retail offices located in North Carolina. The business of the Bank is conducted through its seven operating divisions: HomeTrust Bank, Cherryville Federal Bank, Home Savings Bank of Eden, Industrial Federal Bank of Lexington, Shelby Savings Bank, Tryon Federal Bank and Rutherford County Bank. Its wholly owned subsidiary, Western North Carolina Service Corporation (WNCSC), owns office buildings in Asheville and Hendersonville, North Carolina that are leased to the Bank and several other tenants. Effective July 31, 2013, it announced the completion of its acquisition of BankGreenville Financial Corporation, the holding company for BankGreenville.

Lending activities

The Bank�� loan portfolio is organized into two segments (retail consumer loans and commercial loans) and into four classes within each segment. Its loan portfolio also includes one to four family loans, commercial real estate loans, home equity lines of credit, commercial loans and consumer loans. The Bank underwrites its retail consumer loans using automated credit scoring and analysis tools. These credit scoring tools take into account factors, such as payment history, credit utilization, length of credit history, types of credit in use and recent credit inquiries. One to four family and construction and land/lot loans are to individuals and are typically secured by one-to-four family residential property, undeveloped land, and partially developed land in anticipation of pending construction of a personal residence. Consumer loans include loans secured by deposit accounts or personal property, such as automobiles, boats, and motorcycles, as well as unsecured consumer debt.

The Bank�� commercial loans are centrally underwritten based primarily on the customer�� ability to generate the required cash flow to service the debt in a! ccordance with the contractual terms and conditions of the loan agreement. Real estate owned consists of real estate acquired as a result of customers��loan defaults.

Investment activities

The Company�� investment securities consist of United States Government Agencies, Residential Mortgage-backed Securities of United States Government and Agencies. It also includes Government-Sponsored Enterprises. Securities available for sale were $26.7 million, as of March 31, 2012.

Sources of funds

The Company offers a variety of deposit accounts for individuals, businesses and nonprofit organizations. Deposits are its primary source of funds for lending and investing activities.

Advisors' Opinion:

• [By Tim Melvin]

  Home Trust Bancshares (HTBI) is another example of a cheap, well-financed community bank that has the potential for strong performance over the next couple of years. While the bank�� nonperforming assets are a little above average at 3.87% of total assets, HTBI has plenty of excess capital. The equity-to-assets ratio is more than 20 as of the end of the third quarter, and HTBI has been using its capital to buy back HTBI shares below book value.

Top 10 Cheapest Companies For 2014: Progress Software Corporation(PRGS)

Progress Software Corporation operates as an enterprise software company worldwide. Its products include Progress OpenEdge platform, which offers development tools, application servers, application management tools, and an embedded database; Progress Orbix to address enterprise integration problems with standards-based solutions; and Progress ObjectStore, an object data management system to store data faster than relational database management system or file-based storage system. The company?s products also comprise Progress Responsiveness Process Management suite for business users; Progress Control Tower, an interactive business control panel; Progress Sonic, which comprises an enterprise messaging system and the enterprise service buses; Progress Actional that provides operational and business visibility, root cause analysis, and policy-based security and control of services; Progress Apama, which offers tools for creating, testing, and deploying strategies for applicat ions, including algorithmic trading, market aggregation, smart order routing, market surveillance and monitoring, and risk management; Progress Savvion BusinessManager, a business process management software; and Fuse products that provide customers with access to professional open source integration and messaging software. In addition, it offers Progress DataDirect Connect products, which provide data connectivity components; Progress DataDirect Shadow to provide foundation architecture for standards-based mainframe integration; and Progress Data Services product set that offers data integration for distributed applications. Further, the company provides maintenance, consulting, training, and customer support services. Progress Software Corporation sells its products to independent software vendors, original equipment manufacturers, and system integrators through direct sales force and independent distributors. The company was founded in 1981 and is based in Bedford, Massac husetts.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Progress Software (NASDAQ: PRGS) shares tumbled 10.11 percent to $22.82 after the company issued a weak Q1 forecast.

  21Vianet Group (NASDAQ: VNET) was down, falling 6.18 percent to $25.94 on Q4 results.

• [By Garrett Cook]

  In trading on Friday, technology shares were relative leaders, up on the day by about 0.31 percent. Top gainers in the sector included Aware (NASDAQ: AWRE), up 15.4 percent, and Progress Software (NASDAQ: PRGS), up 7.7 percent.

• [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

  Progress Software Corp.(PRGS) trimmed its expectations for the fiscal first quarter, as the business-software provider said results were hurt by lower license sales. Shares dropped 12% to $22.27 premarket.

• [By Garrett Cook]

  In trading on Friday, technology shares were relative leaders, up on the day by about 0.31 percent. Top gainers in the sector included Aware (NASDAQ: AWRE), up 15.4 percent, and Progress Software (NASDAQ: PRGS), up 7.7 percent.

Top 10 Cheapest Companies For 2014: Eaton Vance Tax-Managed Global Diversified Equity Income Fund (EXG)

Eaton Vance Tax-Managed Global Diversified Equity Income Fund (the Fund) is a diversified, closed-end investment company. The Fund was established to offer investors sources of potential tax-advantaged income and gains. The Fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The Fund pursues its investment objectives by investing primarily in a diversified portfolio of domestic and foreign common stocks. The Fund invests primarily in dividend-paying domestic and foreign common stocks that qualify for favorable federal income tax treatment. In addition, the Fund writes (sells) stock index call options with respect to a portion of its common stock portfolio value. As of October 31, 2007, the Fund had written call options on 49.9% of its equity holdings. The Fund�� 10 largest equity holdings as of October 31, 2007, included Enel SPA, Nokia Oyj ADR, ENI SPA, Royal Dutch Shell PLC, BP PLC, Cesky Telecom AS, GlaxoSmithKline PLC, EMC Corp., HSBC Holdings PLC and Anadarko Petroleum Corp.

The Fund may invest in Cash Management Portfolio (Cash Management), an affiliated investment company managed by Boston Management and Research (BMR), a subsidiary of Eaton Vance Management (EVM). The Fund had a total return of -4.64% for the period from inception on February 27, 2007, to October 31, 2007.

Advisors' Opinion:

• [By Vivian Lewis]

  Eaton Vance Tax-Managed Global Equity Income Fund (EXG) favors active management in a declining market based on CIO Michael Wilson's strategy for closed end funds.

Top 10 Cheapest Companies For 2014: Actelion Ltd (ATLN.VX)

Actelion Ltd is a Swiss biopharmaceutical holding company that focuses on the discovery, development and commercialization of small molecule drugs. The Company has four approved drugs on the market: Tracleer, an oral dual endothelin receptor antagonist; Veletri, a prostanoid vasodilator; Ventavis, an inhaled formulation of iloprost, and Zavesca, an oral treatment for type 1 Gaucher disease. Furthermore, the Company has a number of compounds various stages of development. The Company operates through a number of worldwide subsidiaries, including Actelion Registration Ltd, which holds marketing authorizations for products marketed in the European Union; Actelion Clinical Research, Inc, engaged in clinical development on behalf of the Company's group; Actelion Re SA, providing insurance solutions for the Company's group and Actelion US Holding Company, engaged in the holding activities of the Company's United States-based units. In September 2013, it acquired Ceptaris Therapeutics, Inc. Advisors' Opinion:

• [By Victor Selva]

  Forest Laboratories has a current ratio of 2.69% which is higher than the ones registered by Endo International Plc (ENDP), Valeant Pharmaceuticals International (VRX) and Cubist Pharmaceuticals Inc. (CBST). For investors looking for a higher ROE, Allergan Inc. (AGN) and Actelion Ltd. (ATLN.VX) are good options.

Top 10 Cheapest Companies For 2014: Peregrine Pharmaceuticals Inc.(PPHM)

Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the research and development of monoclonal antibodies for the treatment of cancer and viral infections. Its products under development include bavituximab, a phosphatidylserine-targeting antibody, which is in Phase II trials for the treatment of front-line and second-line non-small cell lung cancer (NSCLC), and pancreatic cancer; and Cotara, a DNA/histone-targeting antibody that is in Phase II trial for the treatment of recurrent glioblastoma multiforme. The company is also developing bavituximab in combination with ribavirin, which is in Phase II clinical trial for the treatment of patients with genotype-1 hepatitis C virus infection. In addition, it has investigator-sponsored trial programs that evaluate bavituximab for the treatment of patients with liver cancer, second-line castration resistant prostate cancer, HER-2 negative metastatic breast cancer, and locally advanced or metasta tic NSCLC. Further, the company, through its wholly-owned subsidiary, Avid Bioservices, Inc., provides integrated current Good Manufacturing Practices (cGMP) commercial and clinical manufacturing services in the United States, including contract manufacturing of antibodies, recombinant proteins, and enzymes; cell culture development; process development; and testing of biologics for biopharmaceutical and biotechnology companies under cGMP. It has licensing agreements with the University of Texas Southwestern Medical Center; Merck KGaA; SuperGen, Inc.; and Affitech A/S. Peregrine Pharmaceuticals, Inc. intends to sell its products in the United States and internationally in collaboration with marketing partners or through a direct sales force. The company was founded in 1981 and is based in Tustin, California.

Advisors' Opinion:

• [By Rick Munarriz]

  I went out on a limb last week, and now it's time to see how that decision played out.

  I predicted that Noodles & Co. (NASDAQ: NDLS  ) would close lower on the week. After seeing the fresh IPO more than double and command a $1.3 billion market cap far sooner than its fundamentals should allow, I figured it would be in for reality check. A negative Barron's piece kicked off the week in the seemingly appropriate bearish tone, but the shares did start to claw their way back later in the week. It wasn't enough. The shares fell 3% on the week. I was right. I predicted that the tech-heavy Nasdaq would outperform the Dow Jones Industrial Average. (DJINDICES: ^DJI  ) . This has been a tricky call lately, so how did it play out this time? Well, the market closed nicely higher this week. The Nasdaq moved 3.5% higher, and the Dow managed to close just 2.2% higher. I was right. My final call was for Peregrine Pharmaceuticals (NASDAQ: PPHM  ) to beat Wall Street's income estimates in its latest quarter. The upstart biotech tackling cancer through monoclonal antibodies has been posting blowout quarterly results over the past year, and I was banking on seeing the trend continue. Analysts were looking for a loss of $0.06 a share during the quarter, and it came through with exactly that. It wasn't a beat, though, so I was wrong.

  Two out of three? I can do better than that.

• [By Rick Munarriz]

  Peregrine Pharmaceuticals (NASDAQ: PPHM  ) is an upstart biotech targeting the treatment and diagnosis of cancer through monoclonal antibodies. It has a potential winner in its lead candidate that will begin its telltale phase 3 clinical trial later this year.

Top 10 Cheapest Companies For 2014: Atech Holdings Ltd (ATH)

ATech Holdings Limited is an Australia-based company. As of June 30, 2010, the Company was engaged in the investment of its cash reserves. The Company�� controlled entities include SEAA (151 Sturt St, South Melbourne) Pty Limited and SEAA (Boronia) Pty Limited. Advisors' Opinion:

• [By Eric Lam]

  Athabasca Oil Corp. (ATH), which is seeking a joint-venture partner for its Duvernay holdings, jumped 9.3 percent to C$7.97, the most in seven weeks.